Japan’s Kubota Pharmaceutical Holdings announced on the 1st that they will sell smart glasses that can treat myopia for 5800 us dollars.
Due to the fact that customized products will be sold in some optical shops, Kuotian Pharmaceutical has been registered as a medical device in the United States in 2022.
The main cause of myopia is that the axial length of the eye is too long or the curvature of the cornea is too curved, which causes light to enter the eye and cannot form a focus on the retina.
When it falls on the front of the retina, the eyes can only see the near things clearly, but cannot see the distant images.
In this regard, through Kubota Pharmaceutical’s smart glasses, the blurred image of the treatment can be projected around the retina of the wearer (myopia), and the myopia can be treated by shortening the elongated eye axis.
It is reported that myopia can be corrected by wearing it continuously for 60-90 minutes every day, but it is not disclosed how long it needs to be worn and how long it can be maintained after correction.
According to the company’s website, Kubota Glass technology reduces axial length gain by projecting a myopic-focused virtual image generated by Micro LEDs around the field of vision to stimulate the retina.
The smart glasses use nanotechnology to actively stimulate the retina for a short period of time to slow the progression of myopia without interfering with daily activities. The company now plans to hand over all the data to the scientific community for publication.
Currently Kubota plans to develop smart contact lenses to slow the progression of myopia, and it also wants to use these technologies in AR and VR devices to treat the vision of myopic children.